AXGN Axogen Inc

Price (delayed)

$16.53

Market cap

$684.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.54

Enterprise value

$696.87M

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore ...

Highlights
Axogen's gross profit has increased by 29% YoY and by 10% from the previous quarter
The revenue has grown by 27% YoY and by 10% from the previous quarter
Axogen's quick ratio has decreased by 35% YoY but it has increased by 9% from the previous quarter
The company's debt has surged by 101% YoY and by 27% QoQ

Key stats

What are the main financial stats of AXGN
Market
Shares outstanding
41.4M
Market cap
$684.29M
Enterprise value
$696.87M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.71
Price to sales (P/S)
5.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.34
Earnings
Revenue
$130.54M
EBIT
-$20.05M
EBITDA
-$15.62M
Free cash flow
-$25.71M
Per share
EPS
-$0.54
Free cash flow per share
-$0.63
Book value per share
$2.89
Revenue per share
$3.18
TBVPS
$5.06
Balance sheet
Total assets
$210.53M
Total liabilities
$91.83M
Debt
$71.99M
Equity
$118.7M
Working capital
$120.17M
Liquidity
Debt to equity
0.61
Current ratio
6.56
Quick ratio
5.75
Net debt/EBITDA
-0.81
Margins
EBITDA margin
-12%
Gross margin
82.1%
Net margin
-16.9%
Operating margin
-15.2%
Efficiency
Return on assets
-11%
Return on equity
-18.2%
Return on invested capital
-11.1%
Return on capital employed
-10.6%
Return on sales
-15.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXGN stock price

How has the Axogen stock price performed over time
Intraday
3.77%
1 week
0.85%
1 month
6.37%
1 year
31.61%
YTD
-7.65%
QTD
-23.51%

Financial performance

How have Axogen's revenue and profit performed over time
Revenue
$130.54M
Gross profit
$107.12M
Operating income
-$19.79M
Net income
-$22.05M
Gross margin
82.1%
Net margin
-16.9%
AXGN's operating margin is up by 48% YoY and by 13% QoQ
The company's net margin rose by 40% YoY and by 10% QoQ
Axogen's operating income has increased by 35% YoY and by 5% from the previous quarter
Axogen's gross profit has increased by 29% YoY and by 10% from the previous quarter

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation
P/E
N/A
P/B
5.71
P/S
5.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.34
The company's EPS rose by 26% YoY
AXGN's P/B is 80% below its 5-year quarterly average of 28.9 and 4.8% below its last 4 quarters average of 6.0
AXGN's P/S is 46% below its 5-year quarterly average of 9.7 and 15% below its last 4 quarters average of 6.1
The revenue has grown by 27% YoY and by 10% from the previous quarter

Efficiency

How efficient is Axogen business performance
Axogen's return on invested capital has surged by 62% YoY and by 17% QoQ
The company's return on sales rose by 45% YoY and by 12% QoQ
The ROA has increased by 41% YoY and by 6% from the previous quarter
Axogen's ROE has increased by 19% YoY

Dividends

What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time
The total assets is 129% higher than the total liabilities
AXGN's total liabilities has soared by 83% YoY and by 18% QoQ
Axogen's quick ratio has decreased by 35% YoY but it has increased by 9% from the previous quarter
The company's debt is 39% lower than its equity
The debt to equity has soared by 103% YoY and by 30% from the previous quarter
The company's debt has surged by 101% YoY and by 27% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.